Explainer-Some patients reporting COVID rebounds after taking Pfizer pills

Published by

By Michael Erman (Reuters) – More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United States, with the Biden administration working to improve access to the drug. As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment and experiencing improvement. Here is the latest information on these rebounds: How common is a recurrence of COVID symptoms shortly after Paxlovid treatment? Dozens of individuals have reported rebounding COVID symptoms…

Read More

Leave a Reply